- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 12.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 12.87M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 12.83M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $2.56M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $2.16M |
| Capex | Q1 2026 · Mar 31, 2026 | $403K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $3.7M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.29M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $4.29M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $56.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $51.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $98.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $94.62M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $90.05M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $86.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.12M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.18M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $15.88M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $14.16M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $86.42M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $81.2M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $114.39M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $108.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.45 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.46 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.37 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.57M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.61M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $956K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $624K |
| Net Income | Q1 2026 · Mar 31, 2026 | $5.82M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $4.69M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $7.24M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $5.43M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $16.81M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $14.84M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $5.17M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $4.67M |
| Revenue | Q1 2026 · Mar 31, 2026 | $21.98M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $19.51M |